NO913004D0 - Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem. - Google Patents
Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem.Info
- Publication number
- NO913004D0 NO913004D0 NO913004A NO913004A NO913004D0 NO 913004 D0 NO913004 D0 NO 913004D0 NO 913004 A NO913004 A NO 913004A NO 913004 A NO913004 A NO 913004A NO 913004 D0 NO913004 D0 NO 913004D0
- Authority
- NO
- Norway
- Prior art keywords
- acid addition
- optically active
- addition salts
- compounds
- mixtures containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2211208A JP2514855B2 (ja) | 1990-08-08 | 1990-08-08 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO913004D0 true NO913004D0 (no) | 1991-08-01 |
Family
ID=16602123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO913004A NO913004D0 (no) | 1990-08-08 | 1991-08-01 | Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0472325B1 (no) |
JP (1) | JP2514855B2 (no) |
KR (1) | KR100192531B1 (no) |
AT (1) | ATE116296T1 (no) |
AU (1) | AU646276B2 (no) |
CA (1) | CA2048714A1 (no) |
DE (1) | DE69106276T2 (no) |
DK (1) | DK143991A (no) |
ES (1) | ES2066363T3 (no) |
FI (1) | FI101700B1 (no) |
HK (1) | HK1003787A1 (no) |
HU (1) | HU213210B (no) |
NO (1) | NO913004D0 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9320273D0 (en) * | 1993-04-01 | 1993-11-17 | Fisons Corp | Compound useful in therapy |
ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
MX2011006680A (es) | 2008-12-24 | 2011-07-12 | Astrazeneca Ab | Compuestos etanaminicos y su uso para tratar la depresion. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE786875A (fr) * | 1971-07-28 | 1973-01-29 | Astra Pharma Prod | Amide, methode pour sa preparation et ses compositions therapeutiques |
US4696930A (en) * | 1985-04-12 | 1987-09-29 | Hoffmann-La Roche Inc. | N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents |
JPS6452797A (en) * | 1987-01-06 | 1989-02-28 | Takeda Chemical Industries Ltd | Production of crystalline trh-tartrate |
-
1990
- 1990-08-08 JP JP2211208A patent/JP2514855B2/ja not_active Expired - Lifetime
-
1991
- 1991-07-30 AU AU81458/91A patent/AU646276B2/en not_active Ceased
- 1991-08-01 NO NO913004A patent/NO913004D0/no unknown
- 1991-08-07 ES ES91307249T patent/ES2066363T3/es not_active Expired - Lifetime
- 1991-08-07 DK DK143991A patent/DK143991A/da not_active Application Discontinuation
- 1991-08-07 KR KR1019910013652A patent/KR100192531B1/ko not_active IP Right Cessation
- 1991-08-07 DE DE69106276T patent/DE69106276T2/de not_active Expired - Fee Related
- 1991-08-07 HU HU912640A patent/HU213210B/hu not_active IP Right Cessation
- 1991-08-07 EP EP91307249A patent/EP0472325B1/en not_active Expired - Lifetime
- 1991-08-07 AT AT91307249T patent/ATE116296T1/de not_active IP Right Cessation
- 1991-08-08 FI FI913774A patent/FI101700B1/fi active
- 1991-08-08 CA CA002048714A patent/CA2048714A1/en not_active Abandoned
-
1998
- 1998-04-02 HK HK98102795A patent/HK1003787A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI913774A (fi) | 1992-02-09 |
ATE116296T1 (de) | 1995-01-15 |
HUT58292A (en) | 1992-02-28 |
EP0472325A3 (en) | 1992-03-04 |
DK143991A (da) | 1992-02-09 |
HU912640D0 (en) | 1992-01-28 |
DE69106276D1 (de) | 1995-02-09 |
AU646276B2 (en) | 1994-02-17 |
EP0472325A2 (en) | 1992-02-26 |
EP0472325B1 (en) | 1994-12-28 |
FI913774A0 (fi) | 1991-08-08 |
DK143991D0 (da) | 1991-08-07 |
JPH0495072A (ja) | 1992-03-27 |
DE69106276T2 (de) | 1995-05-18 |
ES2066363T3 (es) | 1995-03-01 |
JP2514855B2 (ja) | 1996-07-10 |
HU213210B (en) | 1997-03-28 |
HK1003787A1 (en) | 1998-11-06 |
FI101700B (fi) | 1998-08-14 |
CA2048714A1 (en) | 1992-02-09 |
FI101700B1 (fi) | 1998-08-14 |
KR100192531B1 (ko) | 1999-06-15 |
KR920004334A (ko) | 1992-03-27 |
AU8145891A (en) | 1992-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO174711C (no) | Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater | |
NO891698D0 (no) | Pyridonkarboksylsyrederivater og fremgangsmaate for deres fremstilling. | |
ES2055860T3 (es) | Derivados 2-aminopirimidinona. | |
PH25859A (en) | Composition for treatment of ischemic disorder | |
DK25386A (da) | Pyrazolsulfonamidderivater, fremstilling deraf og herbicid indeholdende samme | |
NO883146D0 (no) | Anti-inflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling. | |
AU649882B2 (en) | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments | |
DK183789A (da) | 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse | |
FI891279A (fi) | Antivirala tetrahydroimidazol /1,4/ benzodiazepin-2-oner. | |
NO913004D0 (no) | Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem. | |
NO158622C (no) | Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet. | |
ES8304971A1 (es) | Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos. | |
MA20369A1 (fr) | Compositions a base de derives de la piperidine ,nouveaux derives de la piperidine et leurs procedes de preparation | |
KR870003986A (ko) | α,α-디아릴-4-아릴-4-하이드록시-1-피페리딘부탄아미드, N-옥사이드유도체 및 그 제조방법 | |
NO170630C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutiskaktive 1-(3-(2-sek.-aminoetoksy)-2-tienyl)-3-fenyl-propanoner og syreaddisjonssalter derav | |
HUT42271A (en) | Fungicidal compositions and process for preparing azolyl-(aryloxymethyl)-dimethyl-pentinol derivatives applicable as active substance | |
TH7859EX (th) | อนุพันธ์ต่างๆของพิริโดนคาร์บอกซิลิคแอซิดชนิดออพทิคัลลีแอคทีฟ | |
TH8805EX (th) | อนุพันธ์ต่าง ๆ ของ 3-แอริลออกซิ-เมธิลเซฟาโลสพอริน, การเตรียมของสารเหล่านี้และการใช้เป็นยาของสารเหล่านี้ |